Upgrade to SI Premium - Free Trial

Marvell (MRVL) PT Raised to $72 at UBS

August 27, 2021 7:37 AM
UBS analyst Timothy Arcuri raised the price target on Marvell (NASDAQ: MRVL) to $72.00 (from $68.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles